Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (141-150 of 238) with videos related to

Pageof 24
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
New population-based reference values for spinal mobility measures based on the 2009-2010 National Health and Nutrition Examination SurveyShervin Assassi, Michael H Weisman, MinJae Lee, et al.
Arthritis and Rheumatism|January 30, 2010
Systemic sclerosis and lupus: points in an interferon-mediated continuumShervin Assassi, Maureen D Mayes, Frank C Arnett, et al.
Plos One|September 6, 2024
PIK-III exerts anti-fibrotic effects in activated fibroblasts by regulating p38 activationSantiago Sanchez, Aaron K McDowell-Sanchez, Sharaz B Al-Meerani, et al.
BMJ Open Respiratory Research|September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)Toby M Maher, Shervin Assassi, Arata Azuma, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
The Open Rheumatology Journal|October 16, 2014
Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han ChineseJiucun Wang, Lin Yi, Xinjian Guo, et al.
Clinical and Experimental Rheumatology|August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationaleDinesh Khanna, Christopher P Denton, Shervin Assassi, et al.
Arthritis Care & Research|August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosisLorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
The Journal of Rheumatology|March 17, 2017
Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis CohortJessica K Gordon, Gandikota Girish, Veronica J Berrocal, et al.
Annals of the Rheumatic Diseases|June 13, 2025
Integrative exome sequencing and machine learning identify MICB and interferon pathway genes as contributors to SSc riskShamika Ketkar, Hongzheng Dai, Lindsay Burrage, et al.
Pageof 24

Showing results (141-150 of 238) with videos related to

Sort By:
Pageof 24
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
New population-based reference values for spinal mobility measures based on the 2009-2010 National Health and Nutrition Examination SurveyShervin Assassi, Michael H Weisman, MinJae Lee, et al.
Arthritis and Rheumatism|January 30, 2010
Systemic sclerosis and lupus: points in an interferon-mediated continuumShervin Assassi, Maureen D Mayes, Frank C Arnett, et al.
Plos One|September 6, 2024
PIK-III exerts anti-fibrotic effects in activated fibroblasts by regulating p38 activationSantiago Sanchez, Aaron K McDowell-Sanchez, Sharaz B Al-Meerani, et al.
BMJ Open Respiratory Research|September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)Toby M Maher, Shervin Assassi, Arata Azuma, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2024
Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular SignaturesNancy Wareing, Xuan Wang, Lynette Keyes-Elstein, et al.
The Open Rheumatology Journal|October 16, 2014
Lack of Association of the CD247 SNP rs2056626 with Systemic Sclerosis in Han ChineseJiucun Wang, Lin Yi, Xinjian Guo, et al.
Clinical and Experimental Rheumatology|August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationaleDinesh Khanna, Christopher P Denton, Shervin Assassi, et al.
Arthritis Care & Research|August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosisLorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
The Journal of Rheumatology|March 17, 2017
Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis CohortJessica K Gordon, Gandikota Girish, Veronica J Berrocal, et al.
Annals of the Rheumatic Diseases|June 13, 2025
Integrative exome sequencing and machine learning identify MICB and interferon pathway genes as contributors to SSc riskShamika Ketkar, Hongzheng Dai, Lindsay Burrage, et al.
Pageof 24